Skip to main content
. 2021 Mar 10;11:603223. doi: 10.3389/fonc.2021.603223

Figure 3.

Figure 3

Overall survival since MPM diagnosis according to BAP1 mutation status for groups A, B (A) and A, B1, B2 (B). Group A: MPM with a BAP1 inactivating mutation/copy number loss; group B: MPM without a BAP1 alteration/not tested; group B1: MPM without a BAP1 alteration; group B2: MPM not tested for a BAP1 alteration. BAP1, BRCA1 associated protein-1; CI, confidence interval; ICPi, immune check-point inhibitors; MPM, malignant pleural mesothelioma; NR, not reached; OS, overall survival.